NSE: SUNPHARMA

Sun Pharmaceutical Industries Limited

We don't have a reliable fair-value estimate for Sun Pharmaceutical Industries Limitedyet - our models need more data before we'll publish a number. You can still explore the company's financials below, or try the free intrinsic-value calculator with your own assumptions.

What Sun Pharmaceutical Industries Limited does

Sun Pharma is India's largest drugmaker, selling generics at home and specialty medicines in the US. Its speciality dermatology and eye-care brands earn higher margins than commodity generics.

Healthcare · Healthcare Services

Health signals

GrowthRevenue +10.0%/yr (3y)Good

Over the last 3 years, revenue grew 10.0%/yr and profit grew 10.6%/yr.

ProfitabilityROE 13.8%Good

Every ₹100 of shareholder money earned ₹13.8 in profit last year, vs a sector median of 10.6%.

DebtD/E 0.06Good

It holds more cash than debt.

Valuation-23% vs estimateWeak

The market price is above our estimated fair-value range (based on stated assumptions).

Quality₹103 cash per ₹100 profitGood

About ₹103 of every ₹100 of reported profit turned into free cash (median, last 5 years); operating cash flow was positive in 5 of 5 years.

Key financialsFY17–FY26

Full statements & analysis →

Revenue	₹58,462 Cr
Net profit	₹11,509 Cr
EPS	₹47.84
Free cash flow	₹8,810 Cr
ROE (latest)	13.8%
Revenue growth (CAGR)	7.1%
Profit growth (CAGR)	4.3%

Peers

Sector overview →

Jeena Sikho Lifecare Limited₹6,363 CrP/E 28.7ROE 47.5%

Syncom Formulations (India) Limited₹1,835 CrP/E 24.0ROE 18.3%

Amwill Health Care Limited₹83 CrP/E 7.5ROE 13.6%

Caplin Point Laboratories Limited₹20,942 CrP/E 32.7ROE 18.1%

Acutaas Chemicals Limited₹27,701 CrP/E 77.8ROE 21.5%

Natco Pharma Limited₹14,610 CrP/E 10.3ROE 15.4%

Ask AI about Sun Pharmaceutical Industries LimitedChat with Intrynsic's research agent about results, risks and filings.Sign up free →Track it in your watchlistFair-value alerts, result-day briefs and portfolio analytics.Sign up free →See the full model workingsEvery assumption, per-model trace, reverse DCF and peer lens.Sign up free →

Frequently asked questions

What does Sun Pharmaceutical Industries Limited do?

Sun Pharma is India's largest drugmaker, selling generics at home and specialty medicines in the US. Its speciality dermatology and eye-care brands earn higher margins than commodity generics.

Which sector does Sun Pharmaceutical Industries Limited belong to?

Sun Pharmaceutical Industries Limited operates in the Healthcare sector (Healthcare Services industry) and is listed on the NSE as SUNPHARMA.

What is Sun Pharmaceutical Industries Limited's latest annual revenue and profit?

For FY2017, Sun Pharmaceutical Industries Limited reported revenue of ₹31,578 Cr and net profit of ₹7,846 Cr. The full multi-year history is in the Financials section above.

What are Sun Pharmaceutical Industries Limited's EPS and return on equity?

In FY2017, Sun Pharmaceutical Industries Limited recorded earnings per share of ₹29.0 and a return on equity of 21.4%.

How much debt does Sun Pharmaceutical Industries Limited carry?

Sun Pharmaceutical Industries Limited reported total debt of ₹9,832 Cr in FY2017. See the balance-sheet trend in the Financials section for context.

Disclaimer: Intrynsic provides educational and informational analysis only. Fair-value figures are estimates based on stated assumptions - they are not investment advice, research recommendations, or an offer to transact in any security. Intrynsic is not a SEBI-registered investment adviser or research analyst. Markets carry risk; please do your own research or consult a registered adviser before making investment decisions. Prices shown may be delayed end-of-day values. Terms · Privacy